18-PUB: The Efficacy and Safety of Oral Antidiabetic Drugs Added to Short-Term CSII in Patients with Type 2 Diabetes
Objective: Short-term continuous subcutaneous insulin infusion (CSII) has been proved to be efficacy in T2D patients. However, limited evidence is available about the effect of oral anti-diabetic drugs (OADs) added to short-term CSII in T2D. This study is aimed to compare the efficacy of OADs added...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73, p.1 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!